JP2014500263A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500263A5
JP2014500263A5 JP2013540910A JP2013540910A JP2014500263A5 JP 2014500263 A5 JP2014500263 A5 JP 2014500263A5 JP 2013540910 A JP2013540910 A JP 2013540910A JP 2013540910 A JP2013540910 A JP 2013540910A JP 2014500263 A5 JP2014500263 A5 JP 2014500263A5
Authority
JP
Japan
Prior art keywords
composition
biotec
bcc
deposited
culture collection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013540910A
Other languages
English (en)
Japanese (ja)
Other versions
JP5913353B2 (ja
JP2014500263A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/MY2010/000307 external-priority patent/WO2012074351A1/en
Publication of JP2014500263A publication Critical patent/JP2014500263A/ja
Publication of JP2014500263A5 publication Critical patent/JP2014500263A5/ja
Application granted granted Critical
Publication of JP5913353B2 publication Critical patent/JP5913353B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013540910A 2010-11-29 2010-11-29 腫瘍細胞毒性剤およびその方法 Expired - Fee Related JP5913353B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MY2010/000307 WO2012074351A1 (en) 2010-11-29 2010-11-29 Tumour cytotoxic agent and methods thereof

Publications (3)

Publication Number Publication Date
JP2014500263A JP2014500263A (ja) 2014-01-09
JP2014500263A5 true JP2014500263A5 (enExample) 2014-02-20
JP5913353B2 JP5913353B2 (ja) 2016-04-27

Family

ID=46172112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013540910A Expired - Fee Related JP5913353B2 (ja) 2010-11-29 2010-11-29 腫瘍細胞毒性剤およびその方法

Country Status (7)

Country Link
US (2) US9480721B2 (enExample)
EP (1) EP2646042A4 (enExample)
JP (1) JP5913353B2 (enExample)
KR (1) KR101747815B1 (enExample)
BR (1) BR112012021624A2 (enExample)
SG (1) SG183544A1 (enExample)
WO (1) WO2012074351A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102735818B1 (ko) * 2015-01-23 2024-11-28 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 암 예방에서 단쇄 지방산의 용도
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
AU2020416346B2 (en) 2019-12-31 2024-05-02 Gi Biome Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases, comprising same
WO2021172900A1 (ko) 2020-02-26 2021-09-02 주식회사 지아이바이옴 락토바실러스 헬베티쿠스 균주 및 이를 포함하는 염증성 질환의 예방 또는 치료용 조성물
US20230405063A1 (en) * 2020-09-30 2023-12-21 Chengdu Kuachangaopu Medical Technology Co., Ltd. Use of probiotic component and pharmaceutical composition containing probiotic component
AU2022243439B2 (en) * 2021-03-22 2026-02-26 Gi Biome Lactobacillus plantarum gb104 strain and composition comprising same for prevention or treatment of cancer
US20250222046A1 (en) * 2022-02-10 2025-07-10 Gi Biome Inc. Composition for prevention or treatment of cancer using combined therapy, comprising lactobacillus plantarum strain and anticancer drug
CN116144530B (zh) * 2022-11-17 2023-07-21 朗恒科技集团有限公司 一株植物乳杆菌ay01及其应用
WO2024167277A1 (ko) * 2023-02-06 2024-08-15 주식회사 지아이바이옴 락토바실러스 플란타룸 균주 및 면역세포의 병용 요법을 이용한 암 예방 또는 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009093447A1 (ja) * 2008-01-22 2009-07-30 National University Corporation Asahikawa Medical College 消化器癌に対する抗腫瘍剤
WO2010064373A1 (ja) * 2008-12-04 2010-06-10 国立大学法人広島大学 Ｉｌ－８阻害剤およびその製造方法
CN102292430B (zh) 2009-04-09 2014-11-19 马来西亚博特拉大学 单胃动物饲料
MY158907A (en) * 2009-08-10 2016-11-30 Univ Putra Malaysia Upm Metabolites in animal feed

Similar Documents

Publication Publication Date Title
CN103421715B (zh) 一种鼠李糖乳杆菌及其应用
PH12015500633A1 (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
RU2010142489A (ru) Штамм lactobacillus rhamnosus
JP2016537410A5 (enExample)
FI2787843T4 (fi) Menetelmä pakastekuivatun mikro-organismikoostumuksen valmistamiseksi
WO2015170839A1 (ko) 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
JP2008538288A5 (enExample)
CN102618452B (zh) 唾液乳杆菌及其代谢物的制备方法和组合物以及应用
FR2888468B1 (fr) Produits alimentaires fermentes contenant des souches probiotiques, et leur procede de preparation
RU2012134407A (ru) Способ приготовления биомассы, содержащей плантарицин, и ее применение в медицинских целях
CN110023484A (zh) 一种假小链状双歧杆菌及其培养方法和应用
CN110023486A (zh) 一种嗜酸乳杆菌及其培养方法和应用
JP2013501775A5 (enExample)
FI20075539A0 (fi) Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
WO2009005123A1 (ja) インターフェロンβ産生促進剤及びその製造法
JP2014526266A5 (enExample)
FR2888469B1 (fr) Produits alimentaires fermentes contenant des souches probiotiques, et leur procede de preparation
JP2015533484A5 (enExample)
RU2007146645A (ru) Препарат бактериальный для производства ферментированных мясных изделий и биотрансформации мясного сырья
TW200700074A (en) Inducer of t cell apoptosis
WO2012042223A3 (en) Foodstuff fermented with a lactic acid producing bacteria
JP2012055288A (ja) 安定化された生菌製剤およびその製造方法。
WO2011133681A3 (en) Low/high dose probiotic supplements and methods of their use
WO2012138477A3 (en) Probiotic bacterial strains and method of use to decrease mortality due to bacterial disease
RU2014108605A (ru) НОВЫЙ ШТАММ L. bulgaricus, СПОСОБНЫЙ ИНГИБИРОВАТЬ АДГЕЗИЮ ШТАММОВ Н. pylori К ЭПИТЕЛИАЛЬНЫМ КЛЕТКАМ